Status: Recruiting
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
This is a phase IV post-marketing study for MagnetOs Putty and MagnetOs Easypack Putty. MagnetOs is a synthetic bone graft extender product that is routinely used by surgeon as treatment for hindfoot and ankle disorders. In this study, MagnetOs Putty and MagnetOs Easypack Putty will be use according to the latest Instructions For Use, standalone in the foot and ankle.
Participants needed: 126
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Kuros Biosurgery AGUpdated: Apr 9, 2026Locations: 5
Eligibility criteria
Patient is able to read/be read, understand, and provide written informed consen... [+24]